Ionis Pharmaceuticals (IONS) Non Operating Income (2017 - 2026)
Ionis Pharmaceuticals (IONS) recorded quarterly Non Operating Income of -$456000.0 in Q1 2026, up 97.2% quarter-over-quarter from -$16.3 million in Q4 2025, and down 198.06% on a YoY basis from $465000.0 in Q1 2025.
Ionis Pharmaceuticals (IONS) Non Operating Income (2017 - 2026) Analysis & Trends
Ionis Pharmaceuticals' Non Operating Income history runs 10 years deep, the most recent figure standing at -$456000.0 for Q1 2026.
- In Q1 2026, Non Operating Income fell 198.06% year-over-year to -$456000.0; the TTM figure through Mar 2026 stood at -$16.3 million (down 1171.63% YoY), while the FY2025 annual figure was -$15.4 million, down 1253.87% from the prior year.
- Non Operating Income was -$456000.0 for Q1 2026 at Ionis Pharmaceuticals, up from -$16.3 million in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $11.2 million in Q2 2023 to a low of -$16.3 million in Q4 2025.
- Historically, Non Operating Income has averaged -$419529.4 across 5 years, with a median of $277000.0 in 2024.
- The sharpest annual moves came in 2022 and 2025: Non Operating Income soared 6133.33% in 2022, then slumped 5493.05% in 2025.
- A 5-year view of Non Operating Income shows it stood at $649000.0 in 2022, then slumped by 63.33% to $238000.0 in 2023, then rose by 26.89% to $302000.0 in 2024, then plunged by 5493.05% to -$16.3 million in 2025, then soared by 97.2% to -$456000.0 in 2026.
- The last three Non Operating Income figures came in at -$456000.0 (Q1 2026), -$16.3 million (Q4 2025), and $363000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 5.75 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 444,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 9.35 Mn |
| 10 | Ionis Pharmaceuticals | 12.23 Bn | 10.31 Bn | 243.11 Mn | -456,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -456,000.00 |
| Dec 31, 2025 | -16.29 Mn |
| Sep 30, 2025 | 363,000.00 |
| Jun 30, 2025 | 102,000.00 |
| Mar 31, 2025 | 465,000.00 |
| Dec 31, 2024 | 302,000.00 |
| Sep 30, 2024 | 142,000.00 |
| Jun 30, 2024 | 610,000.00 |
| Mar 31, 2024 | 277,000.00 |
| Dec 31, 2023 | 238,000.00 |
| Sep 30, 2023 | 2.45 Mn |
| Jun 30, 2023 | 11.18 Mn |
| Mar 31, 2023 | 230,000.00 |
| Dec 31, 2022 | 649,000.00 |
| Sep 30, 2022 | 4.71 Mn |
| Jun 30, 2022 | -12.30 Mn |
| Mar 31, 2022 | 187,000.00 |
| Dec 31, 2021 | -477,000.00 |
| Sep 30, 2021 | -469,000.00 |
| Jun 30, 2021 | -8.82 Mn |